{"entity":{"type":"insider","cik":"0001656998","url":"/insider/0001656998","json_url":"/insider/0001656998.json","name":"Azelby Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":12,"first":"2016-11-10","last":"2024-06-18","span_basis":"filed_date"},"name_variants":[{"name":"Azelby Robert","source":"filing","n_filings":12,"first_seen":"2016-11-10","last_seen":"2024-06-18"}],"transactions":[{"id":2404739,"accession":"0001628280-24-028993","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-028993","line_url":"/filing/0001628280-24-028993#line-1","is_derivative":false,"issuer_cik":"0001656998","issuer_name":"ADC Therapeutics SA","issuer_ticker":"ADCT","issuer_name_source":null,"issuer_url":"/issuer/0001656998","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Director","officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6995.0,"shares_display":"6,995","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":20215.55,"total_display":"20,215.55","shares_owned_after":53005.0,"shares_owned_after_display":"53,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-17","filed_date":"2024-06-18","scope":"insider"},{"id":9270535,"accession":"0001209191-18-010536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-010536","line_url":"/filing/0001209191-18-010536#line-1","is_derivative":false,"issuer_cik":"0001656998","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001656998","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4159.0,"shares_display":"4,159","price_per_share":85.55,"price_display":"85.55","price_state":"stated","total_value":355802.45,"total_display":"355,802.45","shares_owned_after":89612.0,"shares_owned_after_display":"89,612","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-15","scope":"insider"},{"id":6096571,"accession":"0001209191-18-010186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-010186","line_url":"/filing/0001209191-18-010186#line-1","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4157.0,"shares_display":"4,157","price_per_share":85.55,"price_display":"85.55","price_state":"stated","total_value":355631.35,"total_display":"355,631.35","shares_owned_after":89614.0,"shares_owned_after_display":"89,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-12","filed_date":"2018-02-14","scope":"insider"},{"id":6859148,"accession":"0001209191-18-009012","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-009012","line_url":"/filing/0001209191-18-009012#line-4","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3497.0,"shares_display":"3,497","price_per_share":85.77,"price_display":"85.77","price_state":"stated","total_value":299937.69,"total_display":"299,937.69","shares_owned_after":93771.0,"shares_owned_after_display":"93,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-09","scope":"insider"},{"id":6330844,"accession":"0001209191-18-007206","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-007206","line_url":"/filing/0001209191-18-007206#line-3","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4167.0,"shares_display":"4,167","price_per_share":85.78,"price_display":"85.78","price_state":"stated","total_value":357445.26,"total_display":"357,445.26","shares_owned_after":96471.0,"shares_owned_after_display":"96,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-02","scope":"insider"},{"id":6657056,"accession":"0001209191-18-005228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005228","line_url":"/filing/0001209191-18-005228#line-2","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102539.0,"shares_display":"102,539","price_per_share":86.25,"price_display":"86.25","price_state":"stated","total_value":8843988.75,"total_display":"8,843,988.75","shares_owned_after":70832.0,"shares_owned_after_display":"70,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-22","filed_date":"2018-01-24","scope":"insider"},{"id":6392922,"accession":"0001209191-18-004661","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-004661","line_url":"/filing/0001209191-18-004661#line-4","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21141.0,"shares_display":"21,141","price_per_share":68.1,"price_display":"68.10","price_state":"stated","total_value":1439702.1,"total_display":"1,439,702.10","shares_owned_after":78822.0,"shares_owned_after_display":"78,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-17","filed_date":"2018-01-19","scope":"insider"},{"id":6392916,"accession":"0001209191-18-004661","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-004661","line_url":"/filing/0001209191-18-004661#line-3","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7990.0,"shares_display":"7,990","price_per_share":69.95,"price_display":"69.95","price_state":"stated","total_value":558900.5,"total_display":"558,900.50","shares_owned_after":70832.0,"shares_owned_after_display":"70,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-17","filed_date":"2018-01-19","scope":"insider"},{"id":5077235,"accession":"0001209191-17-066652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066652","line_url":"/filing/0001209191-17-066652#line-1","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1816.0,"shares_display":"1,816","price_per_share":44.96,"price_display":"44.96","price_state":"stated","total_value":81647.36,"total_display":"81,647.36","shares_owned_after":70832.0,"shares_owned_after_display":"70,832","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-18","filed_date":"2017-12-20","scope":"insider"},{"id":4423409,"accession":"0001209191-17-059331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-059331","line_url":"/filing/0001209191-17-059331#line-2","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6666.0,"shares_display":"6,666","price_per_share":54.95,"price_display":"54.95","price_state":"stated","total_value":366296.7,"total_display":"366,296.70","shares_owned_after":73332.0,"shares_owned_after_display":"73,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-03","scope":"insider"},{"id":4711036,"accession":"0001209191-17-052872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-052872","line_url":"/filing/0001209191-17-052872#line-1","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12850.0,"shares_display":"12,850","price_per_share":44.95,"price_display":"44.95","price_state":"stated","total_value":577607.5,"total_display":"577,607.50","shares_owned_after":37439.0,"shares_owned_after_display":"37,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-13","filed_date":"2017-09-14","scope":"insider"},{"id":4225240,"accession":"0001209191-17-050959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-050959","line_url":"/filing/0001209191-17-050959#line-1","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12869.0,"shares_display":"12,869","price_per_share":39.95,"price_display":"39.95","price_state":"stated","total_value":514116.55,"total_display":"514,116.55","shares_owned_after":50289.0,"shares_owned_after_display":"50,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-29","filed_date":"2017-08-31","scope":"insider"},{"id":2968420,"accession":"0001209191-16-149491","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-149491","line_url":"/filing/0001209191-16-149491#line-2","is_derivative":false,"issuer_cik":"0001594864","issuer_name":"Juno Therapeutics, Inc.","issuer_ticker":"JUNO","issuer_name_source":null,"issuer_url":"/issuer/0001594864","owner_cik":"0001656998","owner_name":"Azelby Robert","owner_url":"/insider/0001656998","role":"Officer (EVP & Chief Commercial Officer)","officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12921.0,"shares_display":"12,921","price_per_share":24.135,"price_display":"24.14","price_state":"stated","total_value":311848.335,"total_display":"311,848.34","shares_owned_after":35719.0,"shares_owned_after_display":"35,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-10","filed_date":"2016-11-10","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001771910","name":"ADC Therapeutics SA","url":"/issuer/0001771910","role":"Director","n_filings":1,"first_seen":"2024-06-18","last_seen":"2024-06-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001594864","name":"Juno Therapeutics, Inc.","url":"/issuer/0001594864","role":"Officer (EVP & Chief Commercial Officer)","n_filings":11,"first_seen":"2016-11-10","last_seen":"2018-02-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001656998","retrieved_at":"2026-08-21T22:20:38+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}